Gene: STEEP1
Official Full Name: STING1 ER exit protein 1provided by HGNC
Gene Summary: While this gene is well-supported by transcript data, no functional information on its protein products is currently available. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20699 | STEEP1 Knockout cell line (HeLa) | Human | STEEP1 | 1:3~1:6 | Negative | Online Inquiry |
KO20700 | STEEP1 Knockout cell line (HCT 116) | Human | STEEP1 | 1:2~1:4 | Negative | Online Inquiry |
KO20701 | STEEP1 Knockout cell line (HEK293) | Human | STEEP1 | 1:3~1:6 | Negative | Online Inquiry |
KO20702 | STEEP1 Knockout cell line (A549) | Human | STEEP1 | 1:3~1:4 | Negative | Online Inquiry |
STEEP1 Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of the STEEP1 gene's functions and associated pathways. Utilizing the CRISPR-Cas9 genome-editing technology, these cell lines exhibit a complete knockout of the STEEP1 gene, allowing researchers to investigate its role in various biological processes, including cell metabolism, signaling pathways, and disease mechanisms.
The primary function of STEEP1 Gene Knockout Cell Lines is to provide a versatile platform for understanding the physiological and pathological implications of STEEP1 deficiency. By observing differences in cellular behavior compared to wild-type controls, researchers can delineate the specific contributions of STEEP1 to metabolic regulation and associated diseases, including potential implications in cancer and metabolic disorders. The ability to accurately analyze gene function through these knockout models bolsters our understanding of genetic interactions and biological networks.
In the realm of scientific research and clinical applications, these cell lines serve as invaluable tools in drug discovery, biomarker identification, and therapeutic development, paving the way for novel treatments targeting conditions arising from STEEP1 dysregulation. Compared to conventional methods such as RNA interference or transient transfection approaches, the STEEP1 Gene Knockout Cell Lines offer a more stable and complete absence of the target gene, resulting in more reproducible and insightful experimental outcomes.
The distinct advantages of using STEEP1 Gene Knockout Cell Lines lie in their precision, reliability, and compatibility with high-throughput screening assays, making them an attractive option for both academic and pharmaceutical research groups. Researchers and clinicians can derive significant value from the insights gained through these models, driving forward knowledge in genetics and therapeutics.
As a leader in developing specialized genetic tools, our company is committed to delivering high-quality biological products that enhance research capabilities and contribute to impactful scientific discoveries. Our expertise ensures the development of tools that meet rigorous standards, backed by comprehensive support and resources for researchers seeking to maximize their findings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.